3E "Right to Try Act"; permitting the use of investigational drugs, biological
products, or devices for certain eligible patients, providing exceptions;
specifying medical assistance (MA) and early periodic screening, diagnosis, and
treatment (EPSDT) programs does not cover costs for investigational drugs,
biological products, or devices
(je)